MedTrace Logo

A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and Neurostimulation

NCT06235450 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-02-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate the usability of the iTEAR100 generation 2 device in combination with its newly developed iLIDS100 disposable cover.

Conditions

  • MicroBlepharoexfoliation, NuLids, iTEAR100, iLIDS100, Blepharitis, Dry Eye Syndrome

Interventions

DEVICE

iLIDS100

Subject applies iLIDS accessory to the iTEAR100 device. Applies to Eyelid margin similar to commercial products

Sponsors & Collaborators

  • Olympic Ophthalmics, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-19
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06235450 on ClinicalTrials.gov